Authors: L. Neuschlová Published in: Geriatrie a Gerontologie 2018, 7, č. 2: 79-81 Category: Review Article
Insomnia is one of the problems that commmonly occurs among elderly people. Insomnia can be the adverse effect of pharmacotherapy. Some of the drugs for insomnia treatment are potentially unsuitable for seniors. Pharmacotherapy of insomnia for seniors includes the options of utilizing magnesium, plant extracts, guaifenesin, substances acting on the benzodiazepin‘s receptors, some antidepresants, antipsychotics, antihistaminics of the first generation and substances acting on the metalonin‘s receptors.
Keywords: insomnie – benzodiazepine – magnesium – guaifenesine – melatonine
1. Abbasi B, Kimiagar M, Sadechniat K, et al. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo -controlled clinical trial. J Res Med 2012; 17(12): 1161–1169.
2. Takuji Inagaki MD, Tsuyoshi Miyaoka MD, Seiichi Tsuji MD, et al. Adverse Reactions to Zolpidem: Case Reports and a Review of the Literature. Prim Care Companion J Clin Psychiatry 2010; 12(6): PCC.09r00849.
3. Toner LC, Tsambiras BM, Catalano G, et al. Central nervous system side effects associated with zolpidem treatment. Clin Neuropharmacol 2000; 23(1): 54–58.
4. De Haas S, Dingemanse J, Hoever P, et al. Pseudohallucinations after zolpidem intake: a case report. J Clin Psychopharmacol 2007; 27(6): 728–730.
5. Fialová D, Topinková E, Ballóková A, et al. Expertní konsenzus ČR 2012 v oblasti léčiv a lékových postupu potenciálně nevhodných ve stáří. Klin farmakol a farm 2013; 27(1): 18–28.
6. Olde Rikkerd MD, Rigaud AS. Melatonin in elderly patients with insomnia. A systematic review. Z Gerontol Geriatr 2001; 34(6): 491–497.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
